P
Pacira Biosciences (PCRX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Pacira Biosciences (PCRX)
Pacira BioSciences, Inc., formerly Pacira Pharmaceuticals, Inc. is a holding company. The Company is a pharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products, based on its DepoFoam extended rel... Read more
- USD23.85
- USD24.36
- USD23.16
- USD28.63
- -7.50%
- 703M
- 817.70k
- 609.22k
- 1.1B
- 11.16
- -16.50%
- 8.50%
Stock News
yesterday
An upgrade for Apple’s stock? It’s not the endorsement you might think.
MarketWatch
yesterday
Jim Cramer explains how Microsoft, Meta and Nvidia led the Mag 7 pack in the first half of 2025
CNBC
yesterday
Bank of America Comments on Stress Test Results; Plans to Increase Quarterly Dividend 8% to $0.28 Per Share
Yahoo
yesterday
Mark Zuckerberg's costly AI talent push has not cost Meta stock yet. Here's why
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
